Neo-Cortef® with Tetracaine

Veterinary medicine · U.S. Food and Drug Administration, Center for Veterinary Medicine · United States

  • Animal drug application 10524
  • Animal drug product ID 708

What the source publishes

Holder
Zoetis Inc.
Active ingredients
Hydrocortisone Acetate Neomycin Sulfate Tetracaine Hydrochloride
Form
Ointment
Routes
Topical
Supply regime
RX

Names this record is found by

Complete source data
us:fda:animaldrugs:554:708
{
  "form": "Ointment",
  "name": "Neo-Cortef® with Tetracaine",
  "holder": "Zoetis Inc.",
  "routes": [
    "Topical"
  ],
  "smpcUrl": null,
  "marketed": null,
  "useDomain": "veterinary",
  "leafletUrl": null,
  "supplyRegime": "RX",
  "nativeProduct": {
    "routes": [
      "Topical"
    ],
    "species": {
      "Dogs:43": "Dog, No Use Class Stated Or Implied",
      "Cats (Domestic):118": "Cat, No Use Class Stated Or Implied"
    },
    "sortOrder": 0,
    "withdrawals": [],
    "doseFormName": "Ointment",
    "applicationId": null,
    "specifications": "The product contains 5 milligrams of neomycin sulfate, equivalent to 3.5 milligrams of neomycin base, 5 milligrams of hydrocortisone acetate, and 5 milligrams of tetracaine hydrochloride in each gram of ointment.",
    "proprietaryName": "Neo-Cortef® with Tetracaine",
    "proprietaryNameId": 708,
    "statusDescription": "RX"
  },
  "nativeSummary": {
    "noohDate": null,
    "publishDate": "2016-06-01",
    "sponsorName": "Zoetis Inc.",
    "applicationId": 554,
    "applicationType": "N",
    "proprietaryName": "Neo-Cortef® with Tetracaine\n",
    "applicationNumber": 10524,
    "activeIngredientName": "Hydrocortisone Acetate\nNeomycin Sulfate\nTetracaine Hydrochloride\n",
    "applicationStatusCode": "A",
    "applicationStatusValue": null,
    "voluntaryWithdrawalDate": null
  },
  "targetSpecies": [
    {
      "code": "43",
      "label": "Dogs",
      "native": {
        "key": "Dogs:43",
        "population": "Dog, No Use Class Stated Or Implied"
      },
      "sourceId": "us.fda.animal-drugs",
      "population": "Dog, No Use Class Stated Or Implied",
      "canonicalId": "dog",
      "mappingStatus": "mapped",
      "mappingVersion": 1
    },
    {
      "code": "118",
      "label": "Cats (Domestic)",
      "native": {
        "key": "Cats (Domestic):118",
        "population": "Cat, No Use Class Stated Or Implied"
      },
      "sourceId": "us.fda.animal-drugs",
      "population": "Cat, No Use Class Stated Or Implied",
      "canonicalId": "cat",
      "mappingStatus": "mapped",
      "mappingVersion": 1
    }
  ],
  "informationUrl": "https://animaldrugsatfda.fda.gov/adafda/views/#/search",
  "ingredientScope": "application-level; no product-specific composition inferred",
  "nativePublishDate": "2016-06-01",
  "sourceDisposition": "reviewed-veterinary-application-product",
  "useDomainEvidence": {
    "basis": "publisher-dataset-scope",
    "field": "sourceId",
    "value": "us.fda.animal-drugs",
    "version": 1,
    "sourceId": "us.fda.animal-drugs"
  },
  "withdrawalPeriods": [],
  "patientEligibility": "not-assessed",
  "nativeApplicationId": 554,
  "targetSpeciesStatus": "reported",
  "administrativeStatus": "unknown",
  "prescriptionCategory": "unknown",
  "activeIngredientsText": "Hydrocortisone Acetate\nNeomycin Sulfate\nTetracaine Hydrochloride\n",
  "nativeApplicationType": "N",
  "applicationIngredients": [
    {
      "activeIngredientName": "Hydrocortisone Acetate",
      "activeIngredientTolerance": "A tolerance is established for negligible residues of hydrocortisone (as hydrocortisone sodium succinate or hydrocortisone acetate) in milk at 10 parts per billion."
    },
    {
      "activeIngredientName": "Neomycin Sulfate",
      "activeIngredientTolerance": "Tolerances are established for residues of parent neomycin in uncooked edible tissues as follows:\r\n\r\n    a. In cattle, swine, sheep, and goats: 7.2 parts per million  in kidney (target tissue) and fat, 3.6 ppm in liver, and 1.2 ppm in muscle.\r\n\r\n    b. In turkeys:  7.2 ppm in skin with adhering fat, 3.6 parts per million in liver, and 1.2 ppm in muscle.\r\n\r\n    c. In milk: 0.15 part per million."
    },
    {
      "activeIngredientName": "Tetracaine Hydrochloride",
      "activeIngredientTolerance": null
    }
  ],
  "nativeApplicationNumber": 10524,
  "nativeProprietaryNameId": 708,
  "restrictionObservations": [
    {
      "indicationText": "It is indicated for treating acute otitis externa and, to a lesser degree, chronic otitis externa in dogs. In treatment of ear canker and other inflammatory conditions of the external ear canal.",
      "limitationText": "Tetracaine and neomycin have the potential to sensitize. Care should be taken to observe animals being treated for evidence of hypersensitivity or allergy to the product. If such signs are noted, therapy with the product should be stopped. Incomplete response or exacerbation of corticosteroid responsive lesions may be due to the presence of non susceptible organisms or to prolonged use of antibiotic-containing preparations resulting in overgrowth of non susceptible organisms, particularly Monilia.  Federal law restricts this drug to use by or on the order of a licensed veterinarian.",
      "populationText": "Dogs"
    },
    {
      "indicationText": "It is indicated for treating acute otitis externa and, to a lesser degree, chronic otitis externa in cats. In treatment of ear canker and other inflammatory conditions of the external ear canal.",
      "limitationText": "Tetracaine and neomycin have the potential to sensitize. Care should be taken to observe animals being treated for evidence of hypersensitivity or allergy to the product. If such signs are noted, therapy with the product should be stopped. Incomplete response or exacerbation of corticosteroid responsive lesions may be due to the presence of non susceptible organisms or to prolonged use of antibiotic-containing preparations resulting in overgrowth of non susceptible organisms, particularly Monilia.  Federal law restricts this drug to use by or on the order of a licensed veterinarian.",
      "populationText": "Cats"
    }
  ],
  "withdrawalPeriodsStatus": "not-reported",
  "publisherIdentityMeaning": "applicationId/proprietaryNameId are technical website keys; applicationNumber is a separate FDA application reference",
  "nativeNoticeOfHearingDate": null,
  "nativeApplicationStatusCode": "A",
  "nativeVoluntaryWithdrawalDate": null
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.animal-drugs" \
  --data-urlencode "id=us:fda:animaldrugs:554:708"